Lawsuit Overview
August 28, 2015 (Shareholders Foundation) - An investor who currently holds shares of Merge Healthcare Inc. (NASDAQ:MRGE), filed a lawsuit in effort to halt the proposed takeover of Merge Healthcare Inc. by IBM for $7.13 per share.
The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:MRGE stockholders by agreeing to sell Merge Healthcare Inc. too cheaply via an unfair process to IBM.
On August 6, 2015, IBM (NYSE: IBM) and Merge Healthcare Inc. (NASDAQ:MRGE) announced the signing of a merger agreement pursuant to which IBM will acquire Merge Healthcare Inc. (NASDAQ:MRGE). Under terms of the transaction, Merge shareholders would receive $7.13 per share in cash, for a total transaction value of $1 billion.
However, the plaintiff claims that the proposed consideration NASDAQ:MRGE shareholders will receive is grossly inadequate and undervalues Merge Healthcare Inc. In addition, the plaintiff claims that the process is also unfair to NASDAQ:MRGE stockholders.